Crypto for Advisors: The blockchain built to run financial markets

Unlike most layer-1 blockchains that serve as neutral platforms, Injective has taken a specialized approach by building core financial plumbing directly into its base layer. Founded in 2018 by Eric Chen and Albert Chon, Injective began as a decentralized derivatives venue and has evolved into a comprehensive financial layer-1 supporting spot and derivatives markets, lending, stablecoins and tokenized real-world assets.

The blockchain provides native onchain order books and shared modules for derivatives, oracles and token issuance. Its proof-of-stake consensus, built on CometBFT, delivers near-instant finality with block times of approximately 620 milliseconds and average fees around 0.17 cents. The Multi-Virtual-Machine architecture allows Ethereum developers to bring existing code without rebuilding, while connections to Cosmos chains via IBC, Ethereum and Solana aim to create connective tissue for liquidity across networks.

Tokenization and institutional adoption

Injective's infrastructure meets larger markets through tokenization. In August 2026, Injective Institutional Services became an SEC-registered transfer agent, giving it a recognized role in maintaining official securities ownership records. The platform's Injective Mint, launched in July 2026, enables issuers to enforce holder restrictions, jurisdictional controls and redemption permissions.

Early use cases demonstrate growing institutional interest. Pineapple Financial has moved more than $1 billion in mortgage records onchain, while POSCO International and LG CNS are piloting tokenized trade receivables. Through Libre, Injective offers access to tokenized funds associated with BlackRock, Hamilton Lane and Nomura's Laser Digital, including private credit. Tokenized assets that trade and settle on Injective generate fees, linking this activity to INJ.

INJ token mechanics

The INJ token serves multiple functions: paying fees, securing the network through staking and carrying governance votes. Like most proof-of-stake tokens, new INJ is issued as staking rewards, but Injective offsets this by burning tokens funded by ecosystem revenue. Under the Community BuyBack introduced in 2025, participants commit INJ each month in exchange for a pro-rata share of the revenue pool, with the committed INJ permanently burned.

A 2026 upgrade narrowed annual issuance to between 2.20% and 4.40%. By October 2026, more than 7 million INJ had been burned, yet total supply remained near 122.9 million, approximately 22.9% above the 100 million tokens issued at launch. Cumulative issuance has outpaced burns, and whether supply ultimately contracts depends on net issuance, which is influenced by revenue growth and burn pace.

Risks and investment thesis

Adoption remains early, with DeFi total value locked at about $18 million in October 2026, according to DefiLlama. Larger networks are pursuing the same tokenization opportunity, many institutional initiatives are still pilots, regulation could add compliance burdens, and INJ remains volatile. Injective faces competition from established ecosystems like Ethereum and Solana, which have larger developer communities and financial applications.

Despite challenges, Injective offers a differentiated approach to blockchain-based finance, combining purpose-built infrastructure, growing institutional interest in tokenization and a buyback-and-burn mechanism. As institutional pilots mature and onchain financial activity expands, Injective has an opportunity to translate adoption into sustained protocol revenue and stronger token economics.